The increased proliferation and decreased apoptosis observed in BCR/ABL expressing BM null for Gadd45a could play a role in the decreased latency of CML caused by loss of Gadd45a. This evidence concerns the gene GADD45A and chronic myelogenous leukemia, BCR-ABL1 positive.